Vi-Typhoid Conjugate Vaccine (Vi-TCV) for typhoid fever

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Oct 2017: Trial registered, NCT03299426
  2. 21 Feb 2018: Trial started, NCT03299426

The trials

NCT03299426: Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

State
Under way
Phase
Phase 3
People
30,000 planned
Started
21 Feb 2018
Primary completion
30 Jan 2025
Arms
Vi-Typhoid Conjugate Vaccine (Vi-TCV)
Results
None posted
  1. 3 Oct 2017: Trial registered
  2. 21 Feb 2018: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.